Paper36176752
Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer.
Eustace AJ and 5 others. Cancer Drug Resist, 2022. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer. Papers, record 36176752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36176752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References146
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22872785 | TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer. | Cancer Inform | 2012 | https://conductscience.org/library/papers/22872785 | PubMed |
| 2 | 18083096 | Calcium signaling. | Cell | 2007 | https://conductscience.org/library/papers/18083096 | PubMed |
| 3 | 18723000 | Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli. | Biochem Biophys Res Commun | 2008 | https://conductscience.org/library/papers/18723000 | PubMed |
| 4 | 24628114 | Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24628114 | PubMed |
| 5 | 31045815 | Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/31045815 | PubMed |
| 6 | 28386091 | The calcium-cancer signalling nexus. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/28386091 | PubMed |
| 7 | 33042844 | Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer. | Front Oncol | 2020 | https://conductscience.org/library/papers/33042844 | PubMed |
| 8 | 35193095 | CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer. | Cell Calcium | 2022 | https://conductscience.org/library/papers/35193095 | PubMed |
| 9 | 31226817 | Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31226817 | PubMed |
| 10 | 30345906 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30345906 | PubMed |
| 11 | 31443516 | Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge. | Cells | 2019 | https://conductscience.org/library/papers/31443516 | PubMed |
| 12 | 26072287 | Plasma membrane calcium channels in cancer: Alterations and consequences for cell proliferation and migration. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/26072287 | PubMed |
| 13 | 31659121 | Characterization of NCS1-InsP3R1 interaction and its functional significance. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31659121 | PubMed |
| 14 | 17581879 | Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17581879 | PubMed |
| 15 | 23254957 | Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis. | Int J Oncol | 2013 | https://conductscience.org/library/papers/23254957 | PubMed |
| 16 | 22552281 | Selective modulation of subtype III IP₃R by Akt regulates ER Ca²⁺ release and apoptosis. | Cell Death Dis | 2012 | https://conductscience.org/library/papers/22552281 | PubMed |
| 17 | 17517433 | TRPC channels as STIM1-regulated store-operated channels. | Cell Calcium | 2007 | https://conductscience.org/library/papers/17517433 | PubMed |
| 18 | 16543939 | The functional domains in p53 family proteins exhibit both common and distinct properties. | Cell Death Differ | 2006 | https://conductscience.org/library/papers/16543939 | PubMed |
| 19 | 30853353 | Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. | Cancer Cell | 2019 | https://conductscience.org/library/papers/30853353 | PubMed |
| 20 | 30439562 | Calcium signalling and breast cancer. | Semin Cell Dev Biol | 2019 | https://conductscience.org/library/papers/30439562 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42642586 | Calcium dysregulation in breast cancer progression: mechanisms of calcicoptosis and therapeutic implications. | Cancer Gene Ther | 2026 | https://conductscience.org/library/papers/42642586 | PubMed |
| 42570059 | Brief report: Therapeutic benefit of ISA-2011B in colorectal cancer. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42570059 | PubMed |
| 41930179 | Multi-Scale Transcriptomic Sequencing Data Analysis Reveals LINC00467 is Associated with Malignant Progression in Breast Cancer: An In Silico and In Vitro Study. | Oncol Res | 2026 | https://conductscience.org/library/papers/41930179 | PubMed |
| 41033085 | Store-operated calcium entry-based targets for novel cancer therapeutic development. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/41033085 | PubMed |
| 40918151 | CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms. | Open Med (Wars) | 2025 | https://conductscience.org/library/papers/40918151 | PubMed |
| 40647529 | The PI3K/Akt/mTOR Signaling Pathway in Triple-Negative Breast Cancer: A Resistance Pathway and a Prime Target for Targeted Therapies. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647529 | PubMed |
| 40427112 | TP53 Mutation-Specific Dysregulation of Store-Operated Calcium Entry and Apoptotic Sensitivity in Triple-Negative Breast Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427112 | PubMed |
| 40296903 | OTUB2 promotes proliferation and metastasis of triple-negative breast cancer by deubiquitinating TRAF6. | Oncol Res | 2025 | https://conductscience.org/library/papers/40296903 | PubMed |
| 39525038 | Integrated analysis reveals prognostic correlation and immune characteristics of a tumor-associated macrophage-based risk signature in triple-negative breast cancer. | Transl Cancer Res | 2024 | https://conductscience.org/library/papers/39525038 | PubMed |
| 39120634 | Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review. | Med Oncol | 2024 | https://conductscience.org/library/papers/39120634 | PubMed |
| 39058425 | Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial. | Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39058425 | PubMed |
| 38851877 | CarcSeq detection of lorcaserin-induced clonal expansion of Pik3ca H1047R mutants in rat mammary tissue. | Toxicol Sci | 2024 | https://conductscience.org/library/papers/38851877 | PubMed |
| 38584537 | Epigenetic Impact of Curcumin and Thymoquinone on Cancer Therapeutics. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/38584537 | PubMed |
| 37250596 | Comprehensive Membrane N-Glycoproteomics Using Human Breast Cancer Cell Line Pairs. | Mass Spectrom (Tokyo) | 2023 | https://conductscience.org/library/papers/37250596 | PubMed |
| 37183639 | [Cigarette Smoke Induces Gefitinib Resistance in NSCLC Cells via ROS/Sirt3/SOD2 Pathway]. | Zhongguo Fei Ai Za Zhi | 2023 | https://conductscience.org/library/papers/37183639 | PubMed |
Genes47
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36176752
GET https://conductscience.org/api/papers/v1/36176752/references?page=2